Banque Pictet & Cie Sa Arvinas, Inc. Transaction History
Banque Pictet & Cie Sa
- $14.9 Billion
- Q4 2024
A detailed history of Banque Pictet & Cie Sa transactions in Arvinas, Inc. stock. As of the latest transaction made, Banque Pictet & Cie Sa holds 110,619 shares of ARVN stock, worth $967,916. This represents 0.01% of its overall portfolio holdings.
Number of Shares
110,619
Previous 120,824
8.45%
Holding current value
$967,916
Previous $2.98 Million
28.74%
% of portfolio
0.01%
Previous 0.02%
Shares
11 transactions
Others Institutions Holding ARVN
# of Institutions
224Shares Held
70.9MCall Options Held
1.52MPut Options Held
346K-
Vanguard Group Inc Valley Forge, PA7.06MShares$61.8 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA6.73MShares$58.9 Million6.03% of portfolio
-
Black Rock Inc. New York, NY6.26MShares$54.8 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.1MShares$35.9 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY3.33MShares$29.2 Million1.04% of portfolio
About ARVINAS, INC.
- Ticker ARVN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,205,300
- Market Cap $466M
- Description
- Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...